Inventor
MATSUDA SHIGEO
US32 patents
⚠️ This page may combine multiple inventors who share the name “MATSUDA SHIGEO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
28 patentsUS11246933B1Feb 15, 2022
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC30 citations98
US10369226B2Aug 6, 2019
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC25 citations98
US9061063B2Jun 23, 2015
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC41 citations98
US11679158B2Jun 20, 2023
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC7 citations94
US11633479B2Apr 25, 2023
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC11 citations94
US11633480B2Apr 25, 2023
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC11 citations94
US11612657B2Mar 28, 2023
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC9 citations94
US11590229B2Feb 28, 2023
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC11 citations94
US11382979B2Jul 12, 2022
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC18 citations94
US9682922B2Jun 20, 2017
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC39 citations94
US11504391B1Nov 22, 2022
Modified RNA agents with reduced off-target effect
ALNYLAM PHARMACEUTICALS INC18 citations84
US11071784B2Jul 27, 2021
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC5 citations84
US10119136B2Nov 6, 2018
RNAi agents modified at the 4′-C position
ALNYLAM PHARMACEUTICALS INC10 citations84
US10995336B2May 4, 2021
Serpina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC8 citations83
US10808246B2Oct 20, 2020
Oligonucleotide-ligand conjugates and process for their preparation
ALNYLAM PHARMACEUTICALS INC6 citations83
US12364762B2Jul 22, 2025
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations73
US12350338B2Jul 8, 2025
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations73
US12343398B2Jul 1, 2025
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations73
US12239709B2Mar 4, 2025
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations73
US11400158B2Aug 2, 2022
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC1 citations73
US9453043B2Sep 27, 2016
Nucleic acid chemical modifications
ALNYLAM PHARMACEUTICALS INC4 citations72
US11597932B2Mar 7, 2023
Chirally-enriched double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC3 citations70
US12275938B2Apr 15, 2025
Modified RNA agents with reduced off-target effect
ALNYLAM PHARMACEUTICALS INC0 citations62
US12247203B2Mar 11, 2025
Modified RNA agents with reduced off-target effect
ALNYLAM PHARMACEUTICALS INC0 citations62
US12173288B2Dec 24, 2024
Oligonucleotide-ligand conjugates and process for their preparation
ALNYLAM PHARMACEUTICALS INC0 citations62
US11725207B2Aug 15, 2023
Serpina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC1 citations62
US12173287B2Dec 24, 2024
Compositions and methods for improving strand biased
ALNYLAM PHARMACEUTICALS INC0 citations58
US10266484B2Apr 23, 2019
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations52
MANOHARAN MUTHIAH
3 patentsUS9012498B2Apr 21, 2015
Biodegradable lipids for the delivery of active agents
MANOHARAN MUTHIAH104 citations97
US8975389B2Mar 10, 2015
Nucleic acid chemical modifications
MANOHARAN MUTHIAH31 citations93
US8962580B2Feb 24, 2015
Chemical modifications of monomers and oligonucleotides with cycloaddition
MANOHARAN MUTHIAH26 citations91